3-Methoxyphenylacetic acid, also known as homoveratric acid, is a naturally occurring organic compound found in various plants. It's a derivative of phenylacetic acid, with a methoxy group at the 3-position. The compound is of interest in research due to its potential biological activities, including its role in plant metabolism and its potential as a precursor in the synthesis of pharmaceuticals.'
3-methoxyphenylacetic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 15719 |
| CHEMBL ID | 345053 |
| CHEBI ID | 88719 |
| SCHEMBL ID | 229067 |
| MeSH ID | M0081231 |
| Synonym |
|---|
| AC-571 |
| unii-25xlo0t6my |
| 4-10-00-00541 (beilstein handbook reference) |
| 25xlo0t6my , |
| 3-methoxyphenylacetic acid |
| einecs 217-282-8 |
| 3-methoxybenzeneacetic acid |
| brn 2614004 |
| m-methoxyphenylacetic acid |
| BB 0259575 |
| acetic acid, (m-methoxyphenyl)- |
| 1798-09-0 |
| (3-methoxyphenyl)acetic acid |
| inchi=1/c9h10o3/c1-12-8-4-2-3-7(5-8)6-9(10)11/h2-5h,6h2,1h3,(h,10,11 |
| benzeneacetic acid, 3-methoxy- |
| 3-methoxyphenylacetic acid, >=99% |
| chebi:88719 , |
| CHEMBL345053 |
| 2-(3-methoxyphenyl)acetic acid |
| M0858 |
| AKOS000120192 |
| A812488 |
| STL164367 |
| AE-562/43380772 |
| FT-0616009 |
| PS-5820 |
| AM20050568 |
| S6013 |
| (m-methoxyphenyl)acetic acid |
| m-anisylacetic acid |
| SCHEMBL229067 |
| [3-(methyloxy)phenyl]acetic acid |
| (3-methoxyphenyl)-acetic acid |
| 2-(3-methoxylphenyl)acetic acid |
| 3-methoxy-2-phenylacetic acid |
| 3-methoxy phenylacetic acid |
| 3-methoxyphenyl acetic acid |
| (3-methoxy-phenyl)-acetic acid |
| 3-methoxy-phenylacetic acid |
| m-methoxyphenyl acetic acid |
| mfcd00004334 |
| SY001372 |
| W-107814 |
| DTXSID70170865 |
| F2191-0029 |
| 3-methoxyphenylaceticacid |
| CS-W016059 |
| Q10395569 |
| 3-methoxyphenylacetic acid;m-methoxyphenylacetic acid, p-methoxyphenylacetic acid, anisylacetic acid, m-omepaa |
| (3-methoxyphenyl) acetic acid |
| HY-W015343 |
| CK2074 |
| EN300-20581 |
| Z104478986 |
| Class | Description |
|---|---|
| monocarboxylic acid | An oxoacid containing a single carboxy group. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1136186 | Antiinflammatory activity in Wistar rat assessed as inhibition of carrageenan-induced paw edema administered 30 mins prior challenge measured after 3 hrs | 1977 | Journal of medicinal chemistry, May, Volume: 20, Issue:5 | Nonsteroidal antiinflammatory agents. 1. 5-Alkoxy-3-biphenylylacetic acids and related compounds as new potential antiinflammatory agenst. |
| AID1136187 | Acute toxicity in ip dosed ddY mouse measured after 168 hrs | 1977 | Journal of medicinal chemistry, May, Volume: 20, Issue:5 | Nonsteroidal antiinflammatory agents. 1. 5-Alkoxy-3-biphenylylacetic acids and related compounds as new potential antiinflammatory agenst. |
| AID184568 | Tested for inhibition of edema growth in rat | 1980 | Journal of medicinal chemistry, Apr, Volume: 23, Issue:4 | Structure-activity study of antiulcerous and antiinflammatory drugs by discriminant analysis. |
| AID23674 | Partition coefficient (logP) | 1980 | Journal of medicinal chemistry, Apr, Volume: 23, Issue:4 | Structure-activity study of antiulcerous and antiinflammatory drugs by discriminant analysis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (29.09) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||